Equine Rhinopneumonitis-influenza Vaccine

Boehringer Ingelheim’s Vetera 2 XP Horse Vaccine is for the vaccination of healthy horses 4 months of age and older, including pregnant mares. Provides protection against equine influenza (clade 1 and clade 2) and rhinopneumonitis (EHV-1 and EHV-4). Formulated with a unique purification process and adjuvant formulation to trigger a healthy immune response and minimize vaccine reactions.
Contains multiple influenza strains such as Kentucky Lineage (KY/95), Florida sublineage clade 1 (OH/03), and Florida sublineage clade 2 (RI/07) equine influenza strains.

  • Safe for use in pregnant mares.
  • Contains relevant influenza strains as recommended by the Expert Surveillance Panel on Equine Influenza.
  • Dual phase system killed vaccine to offer both rapid and long-lasting immunity.

Labeled for: horses

Species: horse


  • Efficacy has been demonstrated for at least 6 months against OH/03.
  • Store at 35 to 45 °F (2 to 7 °C). Protect from freezing.
  • Do not vaccinate within 21 days before slaughter.
  • Use entire contents when first opened.
  • Anaphylactoid reactions may occur following use. Antidote: Epinephrine.


Shake product well before use. Using aseptic technique, inoculate horses intramuscularly with a 1-ml dose. Administer a second 1-ml dose intramuscularly in 3 to 4 weeks using a different injection site. Revaccinate annually and prior to anticipated exposure with a single 1-ml intramuscular dose.